Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -710238.40% is 35193% below its 4-year average of -2012.39%, near the low end of its 4-year range (-710238.40%–104.88%).
2855.47% below its 12-month average of -24031.29%.
Reported quarterly EBITDA margin; no daily interpolation. Q4 FY2015 (2015-12-31): 45.92%.
EBITDA MARGIN
-710238.40%
EBITDA MARGIN AVG TTM
-24031.29%
EBITDA MARGIN AVG 3Y
-2184.98%
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-2855.47%
CURRENT VS 3Y AVG
-32405.41%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Atossa Therapeutics, Inc.
Market Cap
$25.19M
EBITDA Margin
-710238.40%
TTM Avg
-24031.29%
3Y Avg
-2184.98%
5Y Avg
N/A
Market Cap
$24.33M
EBITDA Margin
-701.04%
TTM Avg
-599.88%
3Y Avg
-518.61%
5Y Avg
-381.18%
Market Cap
$24.34M
EBITDA Margin
-883.91%
TTM Avg
-2536.80%
3Y Avg
-2479.09%
5Y Avg
-2025.77%
Market Cap
$22.43M
EBITDA Margin
-7.62%
TTM Avg
-5.66%
3Y Avg
-2.78%
5Y Avg
-31.67%
Market Cap
$27.68M
EBITDA Margin
-541.66%
TTM Avg
-507.83%
3Y Avg
-427.73%
5Y Avg
-407.72%
Market Cap
$27.84M
EBITDA Margin
-11386.31%
TTM Avg
-11386.31%
3Y Avg
-11386.31%
5Y Avg
-3888.42%
Market Cap
$28.22M
EBITDA Margin
-40038.95%
TTM Avg
-34141.60%
3Y Avg
-20873.74%
5Y Avg
-16727.01%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atossa Therapeutics, Inc. (ATOS) | $25.19M | -710238.40% | -24031.29% | -2184.98% | N/A |
| Kyntra Bio, Inc. (KYNB)vs › | $24.33M | -701.04% | -599.88% | -518.61% | -381.18% |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.34M | -883.91% | -2536.80% | -2479.09% | -2025.77% |
| LeonaBio, Inc. (LONA)vs › | $22.64M | N/A | N/A | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.43M | -7.62% | -5.66% | -2.78% | -31.67% |
| InspireMD, Inc. (NSPR)vs › | $27.68M | -541.66% | -507.83% | -427.73% | -407.72% |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.84M | -11386.31% | -11386.31% | -11386.31% | -3888.42% |
| aTyr Pharma, Inc. (ATYR)vs › | $28.22M | -40038.95% | -34141.60% | -20873.74% | -16727.01% |
| Modular Medical, Inc. (MODD)vs › | $20.54M | N/A | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.59M | -17954.61% | -17954.61% | -17954.61% | -17954.61% |
Gross Margin
0.0%
EBITDA Margin
-710238.4%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2015-12-31 | 45.92% |
| 2015-09-30 | -484.43% |
| 2015-06-30 | -114.90% |
| 2015-03-31 | -171.87% |
| 2014-12-31 | -119431.15% |
| 2014-09-30 | -90986.63% |
| 2014-06-30 | -30974.24% |
| 2014-03-31 | -9475.33% |
| 2013-12-31 | -5582.29% |
| 2013-09-30 | -4410.10% |
| 2013-06-30 | -753.09% |
| 2013-03-31 | -1008.64% |
| 2012-12-31 | 104.88% |
| 2012-09-30 | -1067.61% |
| 2012-06-30 | -518.74% |
| 2012-03-31 | -2724.90% |
| 2011-12-31 | -77566.93% |
